CA
Abbott Diabetes 1360 Sout Alameda CA
AcelRx Pharmaceu 575 ChesapRedwood CCA
Acologix Inc. 3960 PointHayward CA
ACT Biotech Inc. 717 MarketSan Franci CA 94103-210US
Adamas Pharmace 1900 PowelEmeryvilleCA
Aerovance Inc. 2929 7th StBerkeley CA
Afferent Pharmac2755 Campu San MateoCA
Afraxis Inc. 5626 OberliSan Diego CA
AgraQuest Inc. 1540 DrewDavis CA
Alios BioPharma 101 A HickSouth San CA
Allele Biotechno 9924 MesaSan Diego CA
Althea Technologi11040 RoseSan Diego CA
Alvine Pharmaceu 75 ShorewaSan CarlosCA
Amalyte Pharmace 3790 El CaPalo Alto CA
Amarantus Therap The ParkinSunnyvale CA
Ambit Bioscience4215 Sorren San Diego CA
Ambrx Inc. 10975 NortLa Jolla CA
American Biologi1180 WalnChula VistaCA
Amira Pharmaceut 9535 Waple San Diego CA
Amplyx Pharmaceuticals IncSan Diego CA
Amyris Biotechno5885 HollisEmeryvilleCA
Anacor Pharmaceu 1020 East Palo Alto CA 94303-423US
Anaphore Inc. 10931 NortLa Jolla CA
AnaptysBio Inc. 10835 Road San Diego CA
AnaSpec Inc. 2149 O'TooSan Jose CA
Angstrom Pharmac 990 HighlaSolana BeaCA
Antibodies Inc. P.O. Box 1 Davis CA 95617-156US
AntiCancer Inc. 7917 OstroSan Diego CA
Applied Molecula10300 Camp San Diego CA
Applikon Biotech1180 ChessFoster CityCA
Aragon Pharmaceu 4215 SorrenSan Diego CA
Arete Therapeutic7000 ShoreSouth San CA
ARYx Therapeutic6300 Dumba Fremont CA
aTyr Pharma Inc.3565 GenerSan Diego CA
Auspex Pharmaceu 1261 LibertVista CA
AutoGenomics In2251 RutheCarlsbad CA
Avera Pharmaceut 10955 VistSan Diego CA
Avigen Inc. 1301 HarboAlameda CA
Avineuro Pharmac 6605 NancySan Diego CA
AVIVA Bioscience11045 Rosel San Diego CA
Axxora Life Scien6181 CorneSan Diego CA
Bachem Californi3132 KashiTorrance CA
Bayer HealthCare800 DwighBerkeley CA
Bayhill Therapeut1810 Gatew San MateoCA
94502 US www.abbot(888) 522-5226
94063 US (650) 216- (650) 216-6500; info@acelrx.c
94545 US (510) 512- (510) 786-1116; info@acologix
(415) 230- (415) 230-3950; administrator
94608 US (510) 450- (510) 428-0519; info@adamas
94710 US (510) 549- (510) 549-5501; info@aerovan
94403 US (650) 286- (650) 286-1833; info@afferen
92121 US (858) 768- (858) 200-0821; cstengone@afr
95618 US (530) 750- (530) 750-0153; info@agraques
94080 US (650) 635- (650) 872-0584; bd@aliosbiop
92121 US (858) 587- (858) 587- (800) 7587-6645
92121 US (858) 882- (858) 882- (888) 425-8432
94070 US (650) 632- (650) 637-3396; info@alvinep
94306 US (650) 521- (650) 521-9695; info@amalyte.
94085 US (408) 737- (408) 521-3636; info@amarantu
92121 US (858) 334- (858) 334-2199; info@ambitbi
92037 US (858) 875- (858) 453-9511; info@ambrx.
91911 US (619) 429- (619) 429- (800) 227-4473
92121 US (858) 228- (858) 558-8445; info@amirap
US www.amplyx.com
94608 US (510) 450- (510) 225-2645; info@amyrisbi
(650) 543- (650) 543-7660; info@anacor.
92037 US (858) 587- (858) 587-4854; info@anaphor
92121 US (858) 362- (858) 362-6296; corpdev@anap
95131 US (408) 452- (408) 452 (800) 452-5530
92075 US (858) 314- (858) 314-2355; mfinlayson@a
(530) 758- (530) 758- (800) 824-8540
92111 US (858) 654- (858) 268- (800) 511-2555
92121 US (858) 597- (858) 597-4950; info@amevolu
94404 US (650) 578- (650) 578-8836; info@applikon
92121 US (858) 334- (858) 334-4848; info@aragon
94080 US (510) 737- (510) 737-4681; info@aretethe
94555 US (510) 585- (510) 585-2202; info@aryx.com
92121 US (858) 731- (858) 731-8394; info@atyrpha
92081 US (908) 705- (760) 599-1801; newboldr@au
92008 US (760) 804- (760) 804-7382; info@autogen
92130 US (858) 847- (858) 847-0655; info@averaph
94502 US (510) 748- (510) 748-7155; info@avigen.c
92121 US (858) 436- (858) 228-9798; info@avineuro
92121 US (858) 552- (858) 552- (888) AVIVA-BIO
92121 US (858) 550- (858) 550- (800) 550-3033
90505 US (310) 539- (310) 530 (888) 422-2436
94710 US (510) 705- (510) 705-5542; www.pharma.b
94303 US (650) 320- (650) 320-2815; info@bayhilltx
BD Biosciences 2350 QumeSan Jose CA 95131-180US (408) 432- (408) 954 (877) 232-8995
Biocell Laboratori2001 UniveRancho DoCA 90220-641US (310) 537- (310) 637- (800) 222-8382
BioCept Inc. 5810 NancySan Diego CA 92121 US (858) 320- (858) 320- (888) 332-7729
BioGenex Laborat4600 NorriSan RamonCA 94583 US (925) 275- (925) 866 (800) 421-
Biolog Inc. 21124 Cabo Hayward CA 94545 US (510) 785- (510) 782- (800) 284-4949
BIOPAC Systems I42 Aero C Goleta CA 93117 US (805) 685- (805) 685-0067; info@biopac.
BioScreen Testing3904 Del ATorrance CA 90503 US (310) 214- (310) 370-3642; info@bioscree
Biosearch Techno81 Digital Novato CA 94949-575US (415) 883- (415) 883- (800) GENOME1 (436-
Biosite Inc. 9975 Summ San Diego CA 92121 US (858) 805- (858) 695- (888) BIOSITE
BiosPacific Inc. 5980 HortoEmeryvilleCA 94608 US (510) 652- (510) 652- (800) 344-6686
BioSure Inc. 1050 Whisp Grass ValleCA 95945 US (530) 273- (530) 273 (800) 345-2267
Biotium Inc. 3423 InvestHayward CA 94545 US (510) 265- (510) 265- (800) 304-5327
BitTech Inc. P.O. Box 1 Agoura HillCA 91376-149US (805) 495- info@bittech.net; www.bittech.
BrainCells Inc. 3565 GenerSan Diego CA 92121 US (858) 812- (858) 812-7630; jschoeneck@bra
Bryant Consultin169 SaxonyEncinitas CA 92024 US (858) 756- (760) 736-4049; laura@bryant-
Calando Pharmace 129 N. Hill Pasadena CA 91106 US (626) 683- (626) 683-7220; info@caland
CalciMedica Inc. 505 Coast BLa Jolla CA 92037 US (858) 952- (858) 952-5490; info@calcimed
Calmune Corp. 9393 Towne San Diego CA 92121 US (858) 657- (858) 657-0292; www.calmune.
Calzyme Laborato3443 Migue San Luis O CA 93401 US (805) 541- (805) 541 (800) 523-9127
Cambrios Technol2450 BayshMountain CA 94043 US (415) 977- info@cambrios.com; www.camb
Carolus Therapeut5626 OberliSan Diego CA 92121 US (858) 768- (858) 200-0821; info@carolusth
Catalyst Bioscien260 Littlef South San CA 94080 US (650) 871- info@catbio.com; www.catalyst
Cellerant Therape1531 IndusSan CarlosCA 94070 US (650) 232- (650) 232-5495; info@cellerant
Ceregene Inc. 9381 JudiciSan Diego CA 92121-383US (858) 458- (858) 458-8801; info@ceregen
Ceres Inc. 1535 RanchThousand CA 91320 US (805) 376- info@ceresbiotechnology.com;
Cerexa Inc. 1751 HarboAlameda CA 94502 US (510) 747- (510) 747-3940; info@cerexa.c
Cerimon Pharmace 701 Gatewa South San CA 94080 US (650) 827- info@cerimon.com; www.cerim
ChemDiv Inc. 6605 NancySan Diego CA 92121 US (858) 794- (858) 794 (877) CHEMDIV
ChemoCentryx In850 MaudeMountain CA 94043 US (650) 210- (650) 210-2910; info@chemoce
Cholestech Corp.3347 InvesHayward CA 94545-380US (510) 732- (510) 732- (877) 441-7440
Clinimetrics Rese5285 HellySan Jose CA 95138 US (408) 452- (408) 452-0912; info@clinimetr
Clontech Laborato1290 TerraMountain CA 94043 US (650) 919- (650) 424- (800) 662-
Colby Pharmaceut 1095 ColbyMenlo Par CA 94025-233US (650) 333- (650) 323-6215; info@colbyph
CoMentis Inc. 280 Utah ASouth San CA 94080 US (650) 869- (650) 869-7626; press@coment
Continental Lab P6190 CorneSan Diego CA 92121 US (858) 279- (858) 279- (800) 456-7741
Corium Internatio235 ConstiMenlo Par CA 94025 US (650) 298- (650) 298-8012; www.coriumgr
Cortex Biochem I1933 DavisSan LeandrCA 94577 US (510) 568- (510) 568- (800) 888-7713
Cougar Biotechno10990 WilsLos AngeleCA 90024 US (310) 943- (310) 943-8059; info@cougarbi
Crown Bioscience4008 BurtoSanta Clar CA 95054 US (603) 686- (408) 986-0019; busdev@crow
Cylene Pharmaceu 5820 NancySan Diego CA 92121 US (858) 875- (858) 875-5101; info@cylenep
Cyntellect Inc. 6620 MesaSan Diego CA 92121-290US (858) 450- (858) 550-1774; info@cyntellec
Cytolution Inc. 5941 OpticSan Jose CA 95138 US (408) 960- (408) 871-2990; info@cytoluti
Cytyc Prenatal P 1240 Elko Sunnyvale CA 94089 US (408) 745- (408) 745 (888) PRETERM (773-
diaDexus Inc. 343 OysterSouth San CA 94080-191US (650) 246- (650) 246-6499; ir@diadexus.c
DiObex Inc. 600 Townse San Franci CA 94103 US (415) 551- (415) 551-4113; Info@diobex.
Dios Therapeutics320 DuluthPalo Alto CA 94306 US galbrecht@diostherapeutics.co
DNA 2.0 Inc. 1430 O¿¿BrMenlo Par CA 94025 US (650) 853- (650) 853 (877) DNA-TOGO
Eidogen-Sertanty9381 JudiciSan Diego CA 92121 US (858) 964- (775) 822-1721; info@eidogen-
EMD Biosciences10394 PaciSan Diego CA 92121 US (858) 450 (858) 453-3552; www.emdbiosc
Endress+Hauser 4123 E. La Anaheim CA 92807 US (714) 577- (714) 577 (800) 835-5474
Epiphany BioscieOne CaliforSan Franci CA 94111 US (415) 765- (415) 765-7200; info@epiphan
Facet Biotech Co1500 SeapoRedwood CCA 94063 US (650) 454- (650) 454-2000; www.facetbiot
Fate Therapeutics10931 NortLa Jolla CA 92037 US (650) 454- www.fatetherapeutics.com
Femta Pharmaceut 4510 ExecuSan Diego CA 92121 US (858) 622- skeane@femtapharma.com; ww
FibroGen Inc. 225 Gatewa South San CA 94080 US (650) 866- (650) 866-7201; info@fibrogen
FivePrime Therap1650 Owens San Franci CA 94158 US (415) 365- (415) 365-5601; business.deve
Galileo Pharmaceu 5301 Patri Santa Clar CA 95054 US (408) 654- (408) 654-5831; ir@galileopha
Gene Therapy SysDBA Genlan San Diego CA 92121 US (858) 457- (858) 623- (888) 428-0558
Genencor Interna925 Page MPalo Alto CA 94304 US (650) 846- (650) 845-6507; www.genencor
Genentech Inc. 1 DNA WaySouth San CA 94080-499US (650) 225- (650) 225-6000; medinfo@gen
Genomatica Inc. 5405 Moreh San Diego CA 92121 US (858) 824- (858) 824-1772; info@genomat
Genteon Inc. 1155 Camin Del Mar CA 92014-260US (858) 350- (858) 350-9199; sales@genteo
Hana Biosciences7000 ShoreSouth San CA 94080 US (650) 588- (650) 588-2787; info@hanabios
Helixis Inc. 5421 AveniCarlsbad CA 92008 US (760) 688- (760) 683-3366; www.helixis.c
Hitachi Chemical630 Clyde Mountain CA 94043-223US (650) 961- (650) 969- (800) 233-6278
Hycor Biomedical7272 ChapGarden Gr CA 92841 US (800) 382- (714) 933- (800) 382-2527
Ichor Medical Sy6310 NancySan Diego CA 92121 US (858) 550- (858) 550-2092; inquiries@ich
Icon Bioscience I1253 ReamSunnyvale CA 94089 US (408) 734- www.iconbioscience.com
IDM Pharma Inc.5820 NancySan Diego CA 92121 US (858) 860- (858) 860-2600; www.idm-pha
IGeneX Inc. 795 San AnPalo Alto CA 94303 US (650) 424- (650) 424- (800) 832-3200
Imgenex Corp. 11175 FlinSan Diego CA 92121 US (858) 642- (858) 642 (888) 723-GENE (436
Immuno Concepts 9779 BusinSacramentCA 95827 US (916) 363- (916) 363 (800) 251-5115
Ingenuity System1700 Seapor Redwood CCA 94063 US (650) 381- (650) 381-5190; info@ingenuit
Innominata dba 15222-A AvSan Diego CA 92128 US (858) 592- (858) 592 (800) 288-4368
Insert Therapeuti129 N. Hill Pasadena CA 91106 US (626) 683- (626) 683-7220; info@insertt.c
Intarcia Therapeu24650 InduHayward CA 94545 US (510) 782- (510) 782-7801; busdev@intarc
InteKrin Therapeu 4300 El CaLos Altos CA 94022 US (650) 941- (866) 286-2242; info@intekrin.
Intellikine Inc. 10931 N. To La Jolla CA 92037 US (858) 768- (858) 558-5998; busdev@intelli
Intradigm Corp. 3350 W Bay Palo Alto CA 94303 US (650) 855- (650) 855-9699; info@intradig
Ionian Technologi4940 CarroSan Diego CA 92121-173US (858) 642- (858) 642-0997; info@ionian-t
Irvine Scientific 2511 DaimlSanta Ana CA 92705-558US (949) 261- (949) 261- (800) 437-5706
Jennerex Biother201 MissioSan Franci CA 94105 US (415) 281- info@jennerex.com; www.jenne
Juvaris BioTherap866 MalcolBurlingam CA 94010 US (650) 259- (650) 697-8828; info@juvaris.c
KAI Pharmaceutic270 Littlef South San CA 94080 US (650) 244- info@kaipharma.com; www.kai
KaloBios Pharmac260 East GSouth San CA 94080 US (650) 243- (650) 243-3260; admin@kalobi
Kalos Therapeutic4370 La JolSan Diego CA 92122 US (858) 552- (858) 546-9227; info@kalostpx
Kalypsys Inc. 10420 Wate San Diego CA 92121 US (858) 754- (858) 754-3301; info@kalypsys
Kinexis Inc. 4350 La JolSan Diego CA 92122-124US (858) 677- www.kinexisinc.com
LEAD Therapeutic999 BayhillSan Bruno CA 94066 US (650) 737- (650) 737-1633; info@leadther
Limerick BioPhar601 Gatewa South San CA 94080 US (650) 742- mailbox@limerickbio.com; www.
Lipomics Technol3410 IndusWest Sacr CA 95691 US (916) 371- (916) 669-0475; info@lipomics
Lithera Inc. 9191 Towne San Diego CA 92122 US (858) 750- (858) 750-1013; fo@lithera.com
Lumen Therapeut110 BeaconMountain CA 94040 US (650) 641- mcgrane@lumentherapeutics.c
MacuSight Inc. 32980 AlvaUnion CityCA 94587 US (510) 400- (510) 400-1441; info@macusig
Medinox Inc. 6120 PaseoCarlsbad CA 92009 US (760) 603- (760) 603-8558; info@medinox
Meritage Pharma12481 HighSan Diego CA 92130 US (858) 436- (858) 436-1661; information@
Metabolex Inc. 3876 Bay CHayward CA 94545 US (510) 293- (510) 293-9090; info@metabol
Meyer Pharmaceu 1761 KaiseIrvine CA 92614 US (949) 833- (949) 833-8664; info@meyerp
MiraiBio Inc. 601 Gatewa South San CA 94080 US (650) 615- (650) 615- (888) 615-9600
Mixture Sciences3550 GenerSan Diego CA 92121 US (858) 455- (858) 455-3879; information@m
Mo Bio Laborator2746 LokerCarlsbad CA 92010 US (760) 929- (760) 929 (800) 606-6246
Molecular Devic 1311 OrleaSunnyvale CA 94089-113US (408) 747- (408) 747- (800) 635-5577
Monogram Biosci345 OysterSouth San CA 94080-191US (650) 635- ir@monogrambio.com; www.mo
Mountain View Ph 3475-S EdiMenlo Par CA 94025-182US (650) 365- (650) 365-5525; saifer@mvph
Nanogen Inc. 10398 PaciSan Diego CA 92121 US (858) 410- (858) 410 (877) 626-6436
Nanomix Inc. 5980 HortoEmeryvilleCA 94608 US (510) 428- (510) 658 (877) NANOMIX
Nanosys Inc. 2625 Hanov Palo Alto CA 94304 US (650) 331- (650) 331-2101; info@nanosysi
Napo Pharmaceuti 1170 VeterSouth San CA 94080 US (650) 616- (650) 873-8367; info@napoph
Natural Selection3333 N. TorLa Jolla CA 92037 US (858) 455- (858) 455-1560; nsi@natural-se
Nereus Pharmaceu 10480 Wate San Diego CA 92121 US (858) 200- (858) 587-4088; sbeach@nere
Neugenesis Corp863 MittenBurlingam CA 94010 US (650) 689- (650) 259-9435; info@neugene
Neurion Pharmace 1 West Mou Pasadena CA 91103 US (626) 791- (626) 628-0302; billr@neurio
Neurome Inc. 11149 NortLa Jolla CA 92037-103US (858) 677- (858) 677-0458; info@neurom
NexBio Inc. 10665 SorrSan Diego CA 92121 US (858) 452- www.nexbio.com
NovaRx Corp. 6828 NancySan Diego CA 92121 US (858) 552- (858) 638-0882; novarx@novar
Novelix Pharmace 8008 GirarLa Jolla CA 92037 US (858) 454- (858) 729-0465; jansen@noveli
Novocell Inc. 3550 GenerSan Diego CA 92121 US (858) 455- (858) 455-3962; info@novocell
Novozymes Inc. 1445 DrewDavis CA 95618 US (530) 757- (530) 758-0317; info@novozy
Numerate Inc. 1150 BayhilSan Bruno CA 94066 US (650) 472- info@numerate.com; www.num
Nuon Therapeutic 2755 Campu San MateoCA 94403 US (650) 645- (650) 645-1801; pdillon@nuont
Nutek Corp. 1001 WhipHayward CA 94544 US (510) 429- (510) 441-9209; info@nutekco
OncoMed Pharmac 800 ChesapRedwood CCA 94063 US (650) 995- (650) 298-8600; bd@oncomed
Optronics 175 CremoGoleta CA 93117 US (805) 968- (805) 968- (800) 796-8909
Orbigen Inc. 6827 NancySan Diego CA 92121 US (858) 457- (858) 362- (866) ORBIGEN (672-
Osel Inc. 4008 BurtoSanta Clar CA 95054 US (408) 986- (408) 986-0019; info@oselinc.
Pathwork Diagnos 1196 BorreSunnyvale CA 94089 US (408) 400- (408) 400-0838; info@pathwor
Pearl Therapeutic200 SaginaRedwood CCA 94063 US (650) 305- (650) 568-1804; asmith@pearlt
Perlegen Sciences2021 StierlMountain CA 94043 US (650) 625- (650) 625-4510; info@perlege
Pharsight Corp. 321 E. EvelMountain CA 94041-153US (650) 314- (650) 314-3810; info@pharsigh
Phenomix Corp. 5930 CorneSan Diego CA 92121 US (858) 731- (858) 731-5225; info@phenomi
Pherin Pharmaceu 4962 El CaLos Altos CA 94022 US (650) 961- (650) 961-2704; lmonti@pheri
Pico Pharmaceuti4510 ExecuSan Diego CA 92121 US (858) 866- (858) 408-2652; info@picophar
Plexxikon Inc. 91 Bolivar Berkeley CA 94710 US (510) 647- (510) 548-8014; info@plexxiko
POINT Biomedica887L IndusSan CarlosCA 94070 US (650) 596- (650) 596-1402; mkayan@point
Portola Pharmace270 E. GranSouth San CA 94080 US (650) 246- www.portola.com
PrimeGen Biotec213 TechnoIrvine CA 92618 US (949) 428- (949) 727-3875; info@primege
Prometheus Labor 9410 CarrolSan Diego CA 92121 US (858) 824- (858) 824 (888) 423-5227
ProZyme Inc. 1933 DavisSan LeandrCA 94577-126US (510) 638- (510) 638 (800) 457-9444
QED Bioscience I10919 TechSan Diego CA 92127 US (858) 675- (858) 592 (800) 929-2114
Qiagen Inc. 27220 TurnValencia CA 91355 US (805) 294- (805) 295 (800) 426-
Quark Pharmaceut 6501 Dumba Fremont CA 94555 US (510) 402- (510) 402-4021; www.quarkph
Raven BiotechnolOne CorporSouth San CA 94080 US (650) 624- (650) 624-2760; info@ravenbio
Regulus Therapeu 1896 RutheCarlsbad CA 92008-720US 888-REGULinfo@regul888-REGULUS (734-8
Relypsa Inc. 5301 Patri Santa Clar CA 95054 US (408) 200- pr@relypsa.com; www.relypsa.
Roche Palo Alto 3431 Hillv Palo Alto CA 94304-130US (650) 855- paloalto.panews@roche.com; pa
Saegis Pharmaceu 60 Stone PHalf MoonCA 94019 US (650) 560- (650) 560-0211; info@saegisp
SafePath Laborat5909 Sea LiCarlsbad CA 92010 US (760) 929- (760) 431-7759; info@safepath
Santen Inc. 555 Gatewa Napa CA 94558 US (707) 254- (707) 254-3648; info@santenin
Scantibodies Clin9236 Abra Santee CA 92071 US (619) 258- (619) 596- (866) 249-1212
Scantibodies Labo 9336 Abra Santee CA 92071 US (619) 258- (619) 258-9366; cs@scantibodi
SciGene 306 PotrerSunnyvale CA 94085 US (408) 733- (408) 733- (800) 342-2119
Scios Inc. 6500 PaseoFremont CA 94555 US (510) 248- (510) 248-2389; fu@sciosinc.c
Scripps Laborator6838 FlandSan Diego CA 92121-290US (858) 546- (858) 546-5812; contact@scrip
Selective Genetic11545 SorrSan Diego CA 92121 US (858) 793- (858) 793-7243; info@selective
Sirna Therapeutic1700 Owens San Franci CA 94158 US (415) 512- (415) 512-7022; info@sirna.co
Solstice Neurosci701 Gatewa South San CA 94080 US (650) 243- (650) 243- (866) 220-5042
Spectrum Laborat18617 S. BRancho DoCA 90220-643US (310) 885- (310) 885- (800) 634-
Stemagen Corp. La Jolla CA US (858) 453- (858) 225-0376; info@stemage
StemCyte Inc. (SC1589 WestCovina
I CA 91722 US (626) 646- (626) 430- (866) 389-4659
Stratagene Corp.11011 N. TLa Jolla CA 92037 US (858) 373- (858) 777- (8800) 894-1304
Sutro Biopharma310 Utah ASouth San CA 94080 US (650) 392- (650) 872-8924; general@sutro
Synbiotics Corp. 11011 Via San Diego CA 92127 US (858) 451- (858) 451- (800) 228-4305
Synthetic Genomi11149 NortLa Jolla CA 92037 US (858) 754- (858) 754-2988; info@syntheti
Tacere Therapeuti 5941 OpticSan Jose CA 95138 US (408) 960- (408) 960-2207; info@tacerebi
Takeda San Dieg 10410 ScieSan Diego CA 92121 US (858) 622- (858) 550-0526; hr@takedasd.
TargeGen Inc. 9380 JudiciSan Diego CA 92121 US (858) 678- (858) 678-0762; info@targege
Tethys Bioscience5858 HortoEmeryvilleCA 94608 US (510) 420- (510) 601- (888) 697-7339
The Salk Institute10010 NortLa Jolla CA 92037 US (858) 453- (858) 453-8534; communication
TheraCyte Inc. P.O. Box 3 Laguna HillCA 32654 US (949) 280- (949) 215-7637; devices@thera
Theregen Corp. 225 Bush StSan Franci CA 94105 US (415) 439- (415) 439-8304; info@therege
Tioga Pharmaceut 9393 Towne San Diego CA 92121 US (858) 677- (858) 452-8799; info@tiogaph
Tracon Pharmaceu 4510 Execut San Diego CA 92121 US (858) 550- (858) 550-0786; afishman@tr
Traversa Therapeu 10480 Wate San Diego CA 92121-577US (858) 454- www.traversathera.com
TriLink BioTechno9955 MesaSan Diego CA 92121 US (858) 546- (858) 546- (800) 863-6801
Trius Therapeutic6310 NancySan Diego CA 92121 US (858) 452- (858) 677-9975; www.triusrx.c
Twyford Internati15245 TeleSanta PaulCA 93060 US (407) 886- (407) 641- (800) 905-3263
UVP Inc. 2066 W. 11Upland CA 91786 US (909) 946- (909) 946 (800) 452-6788
VasGene Therapeu 1929 ZonalLos AngeleCA 90033 US (323) 221- (323) 221-0076; kvg@vasgene.
Vector Laboratori30 Ingold Burlingam CA 94010 US (650) 697- (650) 697- (800) 227-6666 (for o
Versartis Inc. 500 Ellis S Mountain CA 94043 US (650) 963- info@versartis.com; www.versar
Verus Pharmaceut 12671 HighSan Diego CA
Victory Pharma I11682 El CSan Diego CA
Virobay Inc. 1490 O¿¿BrMenlo Par CA
Vital Therapies In15222 AvenSan Diego CA
Vitreoretinal Tec 2 Venture, Irvine CA
Wyatt Technolog6300 HollisSanta BarbCA
XDx Inc. 3260 BayshBrisbane CA
Xencor Inc. 111 West Monrovia CA
Zenobia Therapeu 505 Coast BLa Jolla CA
92130 US (858) 436- (858) 436 (866) 634-8774
92130 US (858) 720- (858) 720-4501; www.victoryp
94025 US (650) 833- (650) 833-6892; info@virobayi
92128 US (858) 673- (858) 673-6843; info@vitalther
92618 US (949) 753- (949) 753- (877) 478-3301
93117-325US (805) 681- (805) 681-0123; info@wyatt.c
94005 US (415) 287 (415) 287- (888) 255-6627
91016 US (626) 305- (626) 305-0350; info@xencor.c
92037 US (858) 926- info@zenobiatherapeutics.com;
 (888) 522-5226 Miles D. WChairman a3,000 empMediSense acquired bPrivately held Abbott Laboratories (see separ
-6500; info@acelrx.c Thomas A.Chairman; 10 P employFounded in 2005 Privately held
-1116; info@acologix R. Scott G Chairman; 15 employFounded in 1992;BegaFiled for I Raised $110K in financing (1992 and 1996);
-3950; administrator Wolf D. BuCEO; COO an 10 employFounded in 2008 Privately held
-0519; info@adamas Gregory We Chairman a30 employFounded in 2002 Privately held Operations in Bangalore, India
-5501; info@aerovan Mark L. PeCEO and Pr27 employSpun out from Bayer Privately hRaised $32M in Series B financing (8/04);R
-1833; info@afferen Kevin Star Chairman; 5 employeFounded in DecembePrivately hRaised $23M in Series A financing
-0821; cstengone@afrJay LichterCEO; CSO; 5 employeFounded in 2007 Privately held
-0153; info@agraquesMarcus Mea CEO ; Presi54 employFounded inHeadquarterPrivately hRaised $500K in seed financing from priva
-0584; bd@aliosbiop Jack Niels Chairman; 8 employeFounded in 2006 Privately hRaised $8.4M in Series A financing (3/09)
(800) 7587-6645 Jiwu Wang,President 10 employFounded in 1999;Acqu Privately held
(888) 425-8432 Francois FeCo-Chairma180+ emplFounded in 1998;Spun Privately hRaised $23M in Series C financing (1/07)
-3396; info@alvinep Abhay JoshCEO and Pr14 employFounded in 2005 Privately hRaised $21M in Series A financing (9/06);R
-9695; info@amalyte. Chris NelsoChairman; 3 employees Privately held Kemin Industries, Inc.
-3636; info@amarantuMartin D. Chairman 3 employeChanged name from CN Privately held
-2199; info@ambitbi Alan LewisChairman; 85 employFounded in May 2000Privately hRaised $2M Series A financing (12/00);Rais
-9511; info@ambrx. John D. Di Chairman; 22 employFounded in 2003 Privately hRaised $12.5M in Series A preferred stock
(800) 227-4473 Carole BradPresident 25 employFounded and began bPrivately held CRB Inc.
-8445; info@amirap Brad Bolzon Chairman; 50 employFounded in 2005 Privately held
Elaine Her CEO; CSO 2 employeFounded in 2006 Privately hRaised $1.55M
-2645; info@amyrisbi John Melo;P CEO; CCO; 20 employFounded in 2003 Privately hRaised $20MAmyris Brazil;Amyris Fuels LLC
-7660; info@anacor. Mark Leschl Chairman; 14
C employFounded in April 200 Privately Raised $3M in initial funding round (2002)
-4854; info@anaphor Russell G. Chairman; 25 employFounded in 2008 Privately hRaised $8M in seed financing (4/08);Raised
-6296; corpdev@anapTom Smart;Chairman a12 employFounded in 2005 Privately hRaised $33.9M in Series B financing (11/07
(800) 452-5530 Anita HongPresident; 60+ employFounded in 1993;AcquiPrivately held
-2355; mfinlayson@a Dr. Malcol President 4 employeeFounded an 1,000 sq. fPrivately hPrivate placement of 600K shares at $0.50
(800) 824-8540 Richard Kr President 16 employFounded in10,000 sq. Privately held;65% held by employees
(800) 511-2555 Robert HofChairman, 35 employeFounded in10,800 sq. Privately held A/C Diagnostics
-4950; info@amevolu Thomas F. President 110 emploFounded in 1989;Chang Privately h$3.55M private equitEli Lilly and Co. (see separate e
-8836; info@applikon John ChoryPresident 20 employFounded in 1973 Privately held Applikon BV Netherlands
-4848; info@aragon Richard HePresident 25 employees Privately hRaised $8M in Series A financing (5/09);Ra
-4681; info@aretethe James N. TChairman; 10 employFounded in 2003 Privately hRaised $16M in first Series A tranche (2/0
-2202; info@aryx.comPaul GoddaChairman a56 employFounded in 1997;Memb Privately hRaised $25M in placement of Series C prefe
-8394; info@atyrpha Jeffry D. WCEO; Sr. VP10 employFounded in 2006 Privately hRaised $12Pangu Biopharma--Hong Kong
-1801; newboldr@au Pratik Sha Chairman; 5 employeFounded in 2001 Privately hRaised $13.875 in Series B financing (5/08)
-7382; info@autogen Fareed KurChairman, 24 employFounded in 1999 Privately held
-0655; info@averaph Dinu Sen;WCEO; CSO an 20 employFounded in 2001;Memb Privately hRaised $16M (4/02);Raised $8M (11/03);R
-7155; info@avigen.c Zola HorovChairman; 4 employeFounded in October 1Privately hRaised $21.2M in private placement of 3.
-9798; info@avineuro Alexander Chairman an 5 employeFounded in August 2 Privately held
(888) AVIVA-BIO Vytas P. A Chairman; 28
V employFounded and began bPrivately hRaised $5M in Series A financing (11/99);Ri
(800) 550-3033 Georges ChaCEO and Pr30 employeFounded in 1993;BegPrivately held Axxora LLC--U.S.;Alexis Corp.--
(888) 422-2436 Philip Ot President 80 employFounded in 1971;AcqPrivately held
-5542; www.pharma.bJoseph AkePresident, 1,500+ emChanged naBerkeley isPrivately held Bayer HealthCare LLC
-2815; info@bayhilltx David E. T Chairman; 38 employFounded in14,000 sq. Privately hRaised $14.5M (8/02);Raised $35.4M in Seri
 (877) 232-8995 Vincent A. President, 2,300 emplo
Core flow cPrincipal f Privately held;Detail Business uOne of three segments of of BD
(800) 222-8382 Marc M. MPresident 40 employeFounded in 1972 Privately held
(888) 332-7729 Gordon Jank President 13 employFounded and began biPrivately held
(888) 866- Krishan KalChairman; 120 emploFounded in 1981;Memb Privately h$4M private placement (7/97)
(800) 284-4949 Barry R. B Chairman, 40 employFounded in January 1Privately held
-0067; info@biopac. Alan MacyPresident 44 employFounded in10,000 sq. Privately held
-3642; info@bioscree Bradford L President 16 employFounded inFacilities Privately held Pharmaceutical and Biotechnology Servic
(800) GENOME1 (436-Ronald M. President a65 employeFounded in30,000 sq. Privately held
(888) BIOSITE Kim Blicke Chairman an 900 emploFounded in26-acre coPrivately held Biosite International Sarl;Rue des Vignero
(800) 344-6686 Sandy Koshk President 8 employeFounded in3,000 sq. fPrivately held
(800) 345-2267 J. R. Riese CEO 5 employeFounded an 5,000 sq. fPrivately held
(800) 304-5327 Jianwei Ho,President 25 employFounded and began bPrivately held
ech.net; www.bittech. Grant A. BiPresident 10 employFounded in2,000 sq. fPrivately held BitTech OncoLogic Corp.
-7630; jschoeneck@bra Harry HixsoChairman; 34 employees Privately hRaised $17.7M in Series A financing (7/05)
-4049; laura@bryant- Julie BryanPresident 10 employFounded inHeadquarter Privately held
-7220; info@caland James Hami CEO; CSO, 10 employFounded in4,000 sq. fPrivately held Arrowhead Research
-5490; info@calcimed Peter McWil Chairman; 8C employeFounded in DecemberPrivately hSeries A financing (7/06);Series B financing
-0292; www.calmune. Dennis R. Chairman; 19 employFounded in 2006 Privately hRaised $15M in Series A financing
(800) 523-9127 Dr. Muzaff Chairman, 15 employFounded an ProductionPrivately held Calzyme Laboratories Ltd.;102-104 Park L
mbrios.com; www.cambClinton W. Chairman; 8 employeFounded in 2002;ChaPrivately hRaised $12M in Series B financing (2/05)
-0821; info@carolusthJay LichterChairman; 3 employeFounded in 2008 Privately held
bio.com; www.catalystHarold E. ' Chairman; 50 employFounded in 2002 Privately held
-5495; info@cellerant Rick RathmChairman; 30 employFounded in 2002 Privately hRaised $16M in Series B financing (5/05);Ra
-8801; info@ceregen Stephen A.Chairman; 26 P employFounded in20,000 squa Privately hRaised $10.5M in Series A financing (1/01)
esbiotechnology.com; Walter De Chairman; 135 emploFounded in 1997 Privately held
-3940; info@cerexa.c Dirk Thye, Sr. VP, Dru 26 employFounded in July 2005Privately hRaised $50M in first Forest Laboratories
imon.com; www.cerimVaughn M.Chairman; 13 employFounded in NovembePrivately hRaised $70M in Series A financing (10/05)
(877) CHEMDIV Nikolay Sa CEO and Pr550 emploFounded in 1990 Privately held
-2910; info@chemoceThomas Scha President a75 employFounded in 1997;Memb Filed for Raised $5M (1997);Raised $23M (2001);Rai
(877) 441-7440 Warren E. P resident 250 emploFounded in February P1rivately held Inverness Medical Innovations
-0912; info@clinimetr Matthew Sm CEO and Pre300 emploFounded in 1988 Privately held Omnicare Inc.
(800) 424- Carol Lou General M170 emploFounded in March 198 Privately held Takara Bio Inc.
-6215; info@colbyph David Zarl CEO; CSO; 5 employees OperationsPrivately held
-7626; press@comentJohn L. HigChairman; 10 employAcquired the assets Privately hRaised $5.69M in Series A financing (9/05)
(800) 456-7741 David WhitPresident 200 emploFounded in17,000 sq. Privately held
-8012; www.coriumgr Peter Stap CEO and Pr180 emploFounded in 1999 Privately held
(800) 888-7713 Matt Pourfa Chairman, 32 employeFounded in7,800 sq. fPrivately hRaised $11.26M in private place
-8059; info@cougarbi Alan H. AueCEO and Pre 10+ emploFounded in May 2003;Privately hRaised $47.5M in private placement of 27.
-0019; busdev@crow Alex Wu, Ph CEO; Presid250 emploFounded in 2006 Privately held
-5101; info@cylenep William G. President a20 employFounded and began biPrivately hRaised $26.3M in Series B financing (5/05)
-1774; info@cyntellec Robert PatzChairman; 15 employFounded in 1997;Chan Privately hReceived a $1.5M II Small Business Innovative Resea
-2990; info@cytoluti Urs G. WieCEO; Actin5 employees Privately held
(888) PRETERM (773-Andrew E. Chairman; 83 employFounded in 1985;Acqu Privately hRaised $13M in sale of Series 3 convertible preferred
-6499; ir@diadexus.c Patrick PlePresident a64 employFounded in16,250 sq. Privately held
-4113; Info@diobex. David A. CoCEO; VP, D10 employees Privately hRaised $24M in Series B financing (4/07)
 @diostherapeutics.co Glenn AlbrCEO and Pr1 employeFounded in 2006 Privately held
(877) DNA-TOGO Jeremy MinsPresident; 20 employFounded inHeadquarter Privately held
-1721; info@eidogen- Steven MusCEO; CSO; 10+ emploFounded in 2002;Chan Privately held
-3552; www.emdbioscDouglas S. President 230 employEstablishe Manufacturi Privately held Merck KGaA (see separate entr
(800) 835-5474 Dr. WolfganPresident 74 employFounded in31,000 sq. Privately held by Endress +HausEndress+Hauser Group
-7200; info@epiphan Fred Volin CSO; CSO; 10 employFounded in 2006 Privately hRaised $36.5M in Series A financing (3/07)
-2000; www.facetbiot Brad Goodw Chairman; 327 emploFounded in 2008 as aPrivately held Abbott
therapeutics.com John MendlChairman; 25C employFounded in 2007;Form Privately hRaised $30M in Series B financing (11/09)
femtapharma.com; wwStephen F.CEO and Pr2 employeFounded in 2008 Privately hRaised $4M in Series A financing
-7201; info@fibrogen Thomas B. Chairman
N a200 emploIncorporatFibroGen InPrivately h5 offeringsFibroGen Europe Corp.;Tukholma
-5601; business.deve Lewis T. WiChairman; 80P employFounded in 2001;Memb Privately hRaised $18M in Series A financing (5/02);
-5831; ir@galileopha Dave MilligChairman; 70C employAcquired Phytera Ltd.Privately held Edison Pharmaceuticals
(888) 428-0558 Anthony S CEO 20 employFounded in 1998 Privately held Genlantis
-6507; www.genencorRobert MayChairman an 1,240 empFounded inEuropean he Privately held by parent;;Form Danisco A/S
-6000; medinfo@gen Arthur D. LChairman; 11,174 emFounded inManufacturi Formerly l Genentech Developmen Roche Hold
-1772; info@genomat ChristophePresident 18 employFounded in 2000 Privately held
-9199; sales@genteo Pascal Bra President 10 employFounded i Headquarter Privately held
-2787; info@hanabiosSteven R. DCEO and Pr35 employFounded and began biFormerly l Raised $4.7M in private placement (2/04);
-3366; www.helixis.c Alex Dicki CEO and Pr20 employFounded in 2007 Privately hRaised $10.0M (8/07)
(800) 233-6278 Brenton HaPresident a100 employIncorporated in 1983Privately held Hitachi Chemical Diagnostics Ltd., Berkshi
(800) 382-2527 J. David ThChairman, 1P90 employIncorporat17,000 sq. Privately held by pa Hycor BiomStratagene Corp. (see separate
-2092; inquiries@ich Robert BerChairman, 25 employFounded in5,000 sq. fPrivately held
nbioscience.com Vernon G. Chairman; 10 employFounded in 2007 Privately hRaised $10M in Series A financing
-2600; www.idm-pha Sylvie Gre Chairman; 34 employFounded in 1993;Merg Privately hRaised $25IDM SA;172 rue de Charonne;Pari
(800) 832-3200 Nick HarrisPresident 20 employFounded in4,200 sq. fPrivately held
(888) 723-GENE (436Sujay K. Si President 66 employFounded in 1997 Privately held
(800) 251-5115 Bert WilliaPresident 35 employFounded inFacilities Privately held
-5190; info@ingenuit Jake LeschCEO and Pre 70 employFounded in 1998 Privately held
(800) 288-4368 Fred Adler;President; 25 employFounded i 16,000 sq. Privately held
-7220; info@insertt.c John PetroPresident a10 employeFounded in February Privately hRaised $10M in privaArrowhead Research
-7801; busdev@intarcK. Alice L President 35 employFounded in 1997;Chan Privately hRaised $38M in mezzanine round of financi
-2242; info@intekrin. Lowell E. SChairman; 10 employFounded in 2005 Privately hRaised $23M in financing (1/07)
-5998; busdev@intelli Troy WilsonPresident 50 employFounded in 2007 Privately hRaised $51M (7/09)
-9699; info@intradig James N. TChairman; 20 employFounded inRockville, Privately hRaised $2.35M in Series A financing and wa
-0997; info@ionian-t David GalasChairman; 8 employeFounded in SeptembePrivately held
(800) 437-5706 Michael KeChairman, 100 employFounded an 23,500 sq. Privately held IS Japan Japan Energy Corp.
nerex.com; www.jenneBrennan Mu Chairman; 14 employFounded in 2003 Privately hRaised $80Canadian office:;501 Smyth Road;Ottawa,
-8828; info@juvaris.c Grant E. P CEO and Pr17 employFounded and began bio Privately hRaised $1.2M in seed financing (2003, 2004
pharma.com; www.kai John WalkeChairman; 42 employFounded in 2002 Privately hRaised $28M in Series A financing (10/04);
-3260; admin@kalobi James I. HeChairman; 50 employFounded inAdministratPrivately hRaised $4M in seed round financing (6/03)
-9227; info@kalostpx George ColChairman; 5 employeFounded in 2005 Privately held
-3301; info@kalypsys Shehan DisChairman; 120 emploFounded in August 200 Privately hRaised $43M in Series A financing (4/02);Ra
Ron GarrenChairman; 1 employeFounded in 2002 Privately hRaised $900K (2002);Raised $2M (2003)
-1633; info@leadther Peter Myers Chairman an35 employFounded in 2007;To bPrivately hRaised $17.5M in Series A financing (5/07)
@limerickbio.com; www. Corey S. G Chairman; 12
C employFounded in 2004;ChaPrivately hRaised $15M in Series C financing (7/09)
-0475; info@lipomics Roger SalqChairman; 20 employFounded and began biPrivately held
-1013; fo@lithera.comJohn D. DoCEO; CSO; 10 employFounded in 2007 Privately held
@lumentherapeutics.c C. Garriso Director; 3 employeeFounded in 2003 Privately held
-1441; info@macusig David A. We CEO and Pr26 employFounded in 2003 Privately held
-8558; info@medinox Ching-San (Chairman, 18 employFounded an 8,000 sq. fPrivately hRaised $13.8M in private offering of preffe
-1661; information@ Cam L. GarChairman; 3 employeFounded in 2008 Privately hRaised $22.5M in Series A round of financi
-9090; info@metabol Edward Penh Chairman; 60 employFounded in35,000 sq. Privately hRaised $33.5M in private financing (6/97);
-8664; info@meyerp Michael F. CEO; Presi 20 employFounded in13,000 sq. Privately
f held
(888) 615-9600 Masakazu KCEO; Direct167 emploFounded in 1999 Privately held Hitachi So Hitachi Sofware Engineering C
-3879; information@mRichard A. President 12 employFounded an 2,000 sq. fPrivately held
(800) 606-6246 Mark N. BroCEO and Pre20 employeFounded an
11,000 sq. Privately held Molecular Biology Manufacturing;Contrac
(800) 635-5577 Joe KeeganPresident a500 emploFounded in150,000 sq.NYSE--MDS; TSX--MDS (throughMDS, Inc.
grambio.com; www.moWilliam D. Chairman a323 emploFounded in NovemberPrivately held;;Formerly listed on NASDAQ--MGRM
-5525; saifer@mvph Dennis M. CBhairman; 10 employeFounded in6,000 f. s Privately held
(877) 626-6436 Howard C. Chairman a248 emploFounded in51,000 sq. Privately hRaised $26Molecular Elitech Gr
(877) NANOMIX Garrett GruChairman; 23 employFounded in September Privately hRaised $16M in Series C financing (3/05)
-2101; info@nanosysi Stephen GoChairman; 34P employFounded in 2002 Privately hRaised $30M in first closing of second roun
-8367; info@napoph Nezam ToolChairman; 12 employFounded in NovembePrivately held
-1560; nsi@natural-seDavid B. FoCEO; Exec. 15
V employFounded in 1993 Privately held
-4088; sbeach@nere Gary ShearChairman; 33 employFounded in 1998 Privately hRaised $8.6M in first round of financing (
-9435; info@neugene W. Dorsey President 6 employeeFounded in5,600 sq. fPrivately held
-0302; billr@neurio William L. Chairman, 10 employFounded and began bPrivately held
-0458; info@neurom Floyd E. Bl Chairman, 30 employFounded in14,000 sq. Privately hRaised $9M in Series A financing (2000)
Mang Yu, PCEO; Presi 70 employFounded in 2003 Privately held
-0882; novarx@novar Justin MurChairman an 50+ emploFounded in May 1997Privately held
-0465; jansen@noveli Tim Triche Chairman ;7 employeFounded in June 2004Privately hRaised more than $700K to-date (1/06)
-3962; info@novocell Fred MiddleChairman; 35 employFounded inHeadquarter Privately hCompleted six rounds of financing;Raised $
-0317; info@novozy Glenn E. NPresident; 73 employeFounded in38,000 sq. Privately
f held;Parent company, Novozymes A/S
merate.com; www.numGuido Lanza CEO; CSO; 15 employFounded in March 2007 Privately held
-1801; pdillon@nuontArlene Morr Chairman; 6 employeStarted 2007 Privately hRaised $5M in Series A financing (7/07);Ra
-9209; info@nutekco Edward J. President 13 employFounded inIrradiation Privately held
-8600; bd@oncomed Paul J. HasCEO and Pre 71 employFounded in August 2 Privately hRaised $93M in Series B financing (11/08)
(800) 796-8909 Doug MerkGeneral M255 emploFounded in18,000 sq. Privately held Karl Storz Imaging
(866) ORBIGEN (672- Stefan GruPresident 30 employees Privately held
-0019; info@oselinc. Peter Lee, Chairman a10 employeFounded an6,000 sq. fPrivately held
-0838; info@pathwor Richard BasChairman; 50 employFounded in January 2Privately hRaised $2.20M in first round of financing
-1804; asmith@pearlt James YoungChairman; 5 employeFounded in 2006 Privately hRaised $15North Carolina:;Pearl Therapeut
-4510; info@perlege Stephen P. Chairman; 100
C emploFounded in 2000 as aFiled for Raised $101M in private financing (4/01);R
-3810; info@pharsigh Patrick Fl COO; Sr. VP87 employFounded in NovemberPrivately held Certara
-5225; info@phenomi Laura Shawv CEO; Corpo50 employFounded in 2002 by th Privately Raised $40M in private placement of Series
-2704; lmonti@pheri Julian N. S Chairman; 12 employFounded inAdditional Privately hRaised $2MPherin Farmaceutica SA
-2652; info@picophar Bert Liang Chairman; 3 employeFounded in 2008 Privately held
-8014; info@plexxiko Joseph P. SChairman; 62 employFounded in31,000 sq. Privately hRaised $8.2M in Series A financing (5/01);
-1402; mkayan@pointJon Saxe;J Chairman; 48 employFounded in11,500 sq. Privately hRaised $9.3M in second round private plac
Charles HomChairman, 60 employFounded in 2003 Privately hRaised $21M (11/03);Raised $46M (10/05);
 -3875; info@primege Thomas C.KChairman a31 employFounded in28,000 sq. Privately
f held Stem Cell Research division;Nuclear Trans
(888) 423-5227 Tim Sear;J Chairman; 235 emploFounded in 1995;BegaFiled for I Raised $1.2M in Series A financing;Raised
(800) 457-9444 E. J. WegstPresident; 9 employeFounded in 1990;Acqu Privately held
(800) 929-2114 Dr. EdwardChairman; 10 employFounded in7,000 sq. fPrivately held
(800) 718- Peer M. ScCEO, Qiage120 emploFounded in February P1rivately held by parent Qiagen NV
-4021; www.quarkph Philip B. S Chairman; 70 P employFounded in 1997 Privately hRaised $10QBI Enterprises Ltd. ;Weizmann
-2760; info@ravenbio William D. Chairman; 69 employFounded on 60,000 sq. Privately hRaised $48.3M in Series D financing (10/05
888-REGULUS (734-8Kleanthis CEO and Pr35 employFounded as a joint vePrivately held
sa.com; www.relypsa. Scott M. RoChairman; 40 S employSpun out of Ilypsa In Privately hRaised $33M in Series A financing
panews@roche.com; paDavid AustPresident 1,000 empMember--Bi 760,000 sq.Privately held Roche Holding, Ltd.
-0211; info@saegisp John WalkeChairman; 11 employFounded and began biPrivately hRaised $14M in Series A financing (7/01);R
-7759; info@safepath Paul HanseChairman, 17 employFounded and began bPrivately held
-3648; info@santenin Adrian GraPresident 75 employSanten Pharm. Ltd fo Privately held by parent Santen Pharmaceutical Co. Ltd.
(866) 249-1212 Tom CantorPresident; 400+ emplFounded an 60,000 sq. Privately held Scantibodies Laboratory Inc. (s
-9366; cs@scantibodi Tom CantorPresident, 450+ employees, 3 Ph60,000 sq. Privately held, famil Scantibodies Clinical Laboratory;Scantibod
(800) 342-2119 James E. StPresident 15 employSciGene was5,000 sq. fPrivately held
-2389; fu@sciosinc.c Darlene HoSr. VP, Cli 750 emploOriginal company, CaPrivately h$5.5M private placeme Johnson &
-5812; contact@scrip Simon C. KPresident; 25 employeFounded in34,000 sq. Privately held Scripps Laboratories Japan, Inc.;5-3-7, Koi
-7243; info@selective Richard Sc Chairman; 20 employFounded in5,000 sq. fPrivately hSecured more than $23M in equity financin
-7022; info@sirna.co Alan SachsVP, RNA The 68 employFounded in 1992;Memb Privately Raised $29M in privaMerck & Co. Inc.
(866) 220-5042 Dennis L. Chairman, 25+ emploFounded in 2004;Acqu Privately hRaised $85Pennsylvania office:;40 General
(800) 445- Roy T. Edd Chairman a150 emploCreated to supply moPrivately held;;Formerly listed on OTC BB--SPTM
-0376; info@stemage Samuel H. CEO; CSO; 8 employees Privately held
(866) 389-4659 Kenneth GiChairman 68 employFounded in 2000 Privately hRaised $13.7M in financing (7/05)
(8800) 894-1304 Joseph A. CEO 450 emploFounded in 1984;Name Privately held Agilent Technologies
-8924; general@sutro William J. CEO; Presi 23 employFounded in 2003;Chan Privately hRaised $21M in Series B financing (12/07)
(800) 228-4305 Paul R. Ha President a62 employFounded in 1982;FormePrivately h$2M investment by H. & Q. Life Science Venture Part
-2988; info@syntheti J. Craig Ve Chairman, 8 employeFounded in June 200 Privately held
-2207; info@tacerebi Michael J. Chairman, 2 employeFounded in 2006 Privately held
-0526; hr@takedasd. Keith P. WiPresident a150+ emplFounded in January 2Privately hRaised $5.07M in SeriTakeda Pharmaceutical
-0762; info@targege Ivor RoystoChairman; 60 employFounded in 2001;To bPrivately hRaised $10M in Series A financing (4/02);R
(888) 697-7339 Mickey S. Chairman a115 emploFounded in 2002 Privately hRaised $25M in Series D financing (11/09)
-8534; communicationCharles H. Chairman; 906 employe Founded and began bPrivately funded research institute
-7637; devices@thera Dr. Charle President 6 employeFounded and began bPrivately held
-8304; info@therege Michael SiaPresident; 4 employeFounded and began bio Privately held
-8799; info@tiogaph Stuart J.M.Chairman 3 employeFounded in 2005 Privately hRaised $24M in Series A financing (1/06);
-0786; afishman@tr Bertrand CChairman; 7 employeFounded in 2005;Chan Privately held
ersathera.com Hans A. PeCEO and Pr8 employeFounded in 2006 Privately hRaised $2M in Series A financing (2/08)
(800) 863-6801 Richard HoPresident; 37 employFounded in 1996 Privately held
-9975; www.triusrx.c David S. KaChairman; 35 employFouned in 2004;ChanPrivately hRaised $20M in Series A financing (2/07);R
(800) 905-3263 Ginger GofDirector, S 300+ emplFounded in 1982 by vePrivately held Twyford Apopka;4051 Fudge Road;Apopk
(800) 452-6788 Paul WarreChairman; 100 emploFounded in 1932;BegPrivately held Ultra-Violet Products Ltd.
-0076; kvg@vasgene. Raymond A. Chairman a7 employeFounded in 2002 Privately h$4.5M Series A preferred financing (2002)
(800) 227-6666 (for oJames S. WPresident; 50 employFounded in 1976 Privately held Vector U.S.A.
sartis.com; www.versarMark de Boe Chairman; 4 employeFounded in DecembePrivately hRaised $11M in Series A financing (6/09)
 (866) 634-8774 Cam L. Garn
Chairman an25 employFounded i 13,000 sq. Privately
f hRaised $98M in financing ($78M in Series A
-4501; www.victoryp James Newm Chairman; 175 emploFounded in 2003;Enter Privately held North Carolina: Commercial Operations;3
-6892; info@virobayi Robert BootChairman; 9C employeFounded in 2006 Privately hRaised $30M in Series A financing (7/06)
-6843; info@vitalther Terry WintChairman a8 employeHepatix IncorporatedPrivately hRaised $9MVital Therapies (Beijing) Co. Ltd.
(877) 478-3301 Hampar KarCEO; CTO a9 employeFounded in 2000 Privately hRaised $9.9M in financing (6/07)
-0123; info@wyatt.c Philip J. W CEO; Presid45 employeFounded in March 19Privately held
(888) 255-6627 Brook ByersChairman; 72 employFounded in 2000;Memb Filed for Raised $1.4M (5/99);Raised $7.6M (12/00);
-0350; info@xencor.c Bruce L.A. Chairman; 75
P employFounded in 1997;Memb Privately hRaised $3.55M in financing (1/98);Raised $
obiatherapeutics.com;Vicki Nien President a7 employeFounded in June 200 Privately held
 BioSenSys, a portable instrume
Abbott Laboratories (see separate entry) Diabetes Tests Treatments that modulate the
Alta Partners;Kaiser PermanenteDrug Delivery/Design/Formulation 7-Jan The company has developed a
ncing (1992 and 1996);JAIC America;Life Science VentuAllergy Th Toray Industries Inc.;Toray Industries Inc.;University of Maryland at Baltim
NGN Capital Conduct cliCancer;TheBayer HealthCare LLC Development of therapies for p
ns in Bangalore, India Mohr Davidow Ventures;Northgat Infectous diseases;Central Nervous System 10-Mar Cancer indications, including m
es B financing (8/04);RAlta Partners ;Apax P Develop anPulmonary/Lung Disease 6/05;6/06;Focus is on the identification,
es A financing Domain Associates;New Leaf Ven Anti-infla F. Hoffmann-La Roche AG 8-May
Avalon Ventures Central Nervous System Disorders 3/03;9/08;VCM (Visual Cycle Modulation)
d financing from priva Halcyon Capital;Otte Discover, Biofungicides;Bioinsecticides;Ornamental Plants;AgricDeveloping small molecule, Ad
ies A financing (3/09) Therapeutics;Antivirals 8/09;7/07;Initial research focus is on adre
Provide neReagents/Research Materials;RNA interfer6/09;12/09Integrated antibody discovery a
es C financing (1/07) AccelerateGenetic EnBaxter Healthcare Corp. and Baxter Pharmaceutical Solutions LLC;Beckma
es A financing (9/06);RAbbott Biotech VenturDevelop anAutoimmune Disorders 4-Sep Create differentiated Adnectin
Kemin Industries, Inc. Identify a Therapeutics
Cardiovascular Agents;Central Nervous System Disorders
A financing (12/00);RaisApposite Capital;Av Advance mo Cancer;DruActiveSight;Astellas Pharma Inc.;AstraZeneDiscovery and development of
ries A preferred stock 5AM Ventures;Alexand Long-term Protein
g PuCMC Biopharmaceuticals A/S;Eli Lilly and Co.;EMD Serono;F. Hoffmann-La
Become a w Allergy Therapeutics;Anti-inflammatory Th 10-Jun PPAR gamma agonists for neur
Avalon Ventures;Novo A/S;ProspCardiovascGlaxoSmithKline plc 9-Dec Focus is on the development o
Life Science Angels;Tech Coast Infectous Duke University Using kinase inhibitors to repai
azil;Amyris Fuels LLC Advanced Equities In Commercial Genetic EnSanofi-Aventis SA;University of California, Plant diagnostics;MAbs, cell cu
l funding round (2002) Aberdare Ventures;CaDiscover anTherapeutiMedicines for Malaria Venture (MMV);ScheSkinfusion technology
financing (4/08);Raised5AM Ventures;VersantDevelop a nDrug Discovery;Cancer Screening for microbial natural
ries B financing (11/07Alloy Ventures;Avalo Offers a vaTherapeutiF. Hoffmann-La Roche Ltd.;Medical Research HIF prolyl hydroxylase inhibitor
Provide hi Combinatorial Chemistry;Reagents/Research Materials Therapeutics, diagnostics, drug
f 600K shares at $0.50 Hamilton BioVentures; Using platAllergy Therapeutics;Anti-inflammatory T 5-Jun
ManufacturTissue Culture;Allergy/Autoimmune Tests;D11/09;12/ Identification, development an
JAFCO;Daiwa BusinessAnticancerCardiovascOlympus Corp.;Shionogi & Co. Ltd.;SRL;U.S.Technologies include unique el
Eli Lilly and Co. (see separate entry) Maintain aAnticancerBiosite Diagnostics Inc.;Bristol-Myers Squ Allergy;Lipoproteins;Endotoxin
Applikon BV Netherlands Develop, mSofware PFinesse LLC Developing novel medicines to
s A financing (5/09);RaColumn Group;OrbiMed Advisors; Cancer RNA interference technologies
Series A tranche (2/0 Altitude Funds;Alta PDiscover anAnti-inflammatory Therapeutics;Drug Discovery Yeast-derived products to maxi
ement of Series C prefeAscent Biomedical VeBecome a lDrug DelivProcter & Gamble Pharmaceuticals Inc.
opharma--Hong Kong Alta Partners;Cardinal Partners Dermatologics;Anti-inflammatory Therapeu12/08;199Development of vaccines based
eries B financing (5/08)CMEA Capital;Sloan Biotech Fu Cardiovascular Agents;Drug Discovery;The 8/03;4/09;7/08;1/10;2/06
#NAME? Proteomic Targeted Molecular Diagnostics 10/03;6/0 Focused on reducing the time,
;Raised $8M (11/03);RAberdare Ventures;Bay Acquire, i Central NeEli Lilly and Co.;GlaxoSmithKline2/08;9/08 STAR technology platorm: to im
ivate placement of 3. Apex Capital;Biotech Develop inn Drug DelivSDI Diagnostics International Ltd. (division of Sanochemia Pharmazeutika
Discover a Molecular ChemDiv;ChemDiv and Drugs Technology;Th Identifying and developing nov
s A financing (11/99);RiCapitalBio Corp.;ChinIntegrate cCancer TesUndisclosed agreements pending Development of first-in-class di
C--U.S.;Alexis Corp.-- Ampersand Ventures;Develop, pFine Chemicals;Specialty Chemicals;Combin 6/05;4/05;Armored RNA: RNA standards f
Reagents/Research Materials;Peptide/Prot11/05;12/0Combine the power of our KIN
Bayer HealthCare LLC Bayer HealGenetic EnAsklepios;Johnson & Johnson;Nu6/05;2007;Ambrx ReCODE technology (rec
2);Raised $35.4M in Seri A. M. Pappas & AssocTranslate Diabetes TGenentech Inc.;Juvenile Diabet 1987;1996Selection and testing of inbred
 One of three segments of of BD (see separBuild uponAllergy/AuBiotrin International Ltd.;Dynomics BV;RocBlood assessments for identify
Biocell LabDiagnostics;Diagnostic Reagents;Peptide/Pr2004;2006Cardiovascular diseases;Cancer
Develop anNeurobiological Diagnostics;Food Diagnostics;Agricu Radiolabeled drugs
MESBIC Ventures;Oppo Become a w Molecular Abbott Laboratories 8-Feb
Funding fr Continue grContract RAxiohelix and the NARA Institut 5-Aug Disease targets include pancre
Provide pr Biosensors;Central Nervous System Disorders;Circula Development of immune-base
eutical and Biotechnology Services;Medical Device;Cosm Cosmetics;Food Microbiology Small molecules to improve the
Biosearch iReagents/RProdesse Inc. 3/08;2004Creating No Compromise fuels
ternational Sarl;Rue des Vignerons, 1A;Mo Biosite Inc ConsultingAGEN BioMedical;Alethia Biother 4/10;1/07 Usage of boron chemistry to de
Joint venture with Fortron Bio ScMake compo Therapeutic Proteins;Therapeutic Antibodies;Reagents Biosensors, novel diagnostic te
Provide uniConsulting Services;Reagents/Research Materials;FerAtrimers are a new class of pro
Develop andReagents/RAnderson Unicom Group Inc.;C 1/10;5/07;Use of somatic hypermutation
ncoLogic Corp. Thus far awFocus is onAnticancers;Cancer;Contract Research Organization;Fermentation/Microorganism D
ries A financing (7/05)Bay City Capital;Med Develop smCentral NeMitsubishi Pharma Corp.;Organon;Taisho PFocusing on protein research in
Bioinformatics;Cancer;Sofware Programs
Arrowhead Research Arrowhead Research Develop anRNA interfBenitec Ltd.;Calando Pharmaceuticals Inc.;Diagnostic devices for male fer
/06);Series B financingS.R. One Ltd.;Sanderl Discover a Anti-infla CBR Institute for Biomedical Research Inc.
es A financing TherapeutiCrucell NV Small-molecule drugs that disru
Laboratories Ltd.;102-104 Park Lane;CroydonCustom man Food Enzymes;Agriculture Diagnostics;Biosensors;DiaMonoclonal antibodies, immu
es B financing (2/05) Alloy Ventures;ARCH M V ission:;UMolecular Biology;Nanobiotechnology ; Immunological modulators der
Avalon Ventures DevelopmentTherapeutic Proteins;Anti-inflammatory Th11/04;10/ ONCase (methioninase) cancer
Burrill and Co.;Essex Woodland Drug DiscoCentocor Research & Developm7/97;1/98;Validation of a cell surface tar
es B financing (5/05);RaAllen & Company LLC;Develop anAutoimmune Progenitor Cell Therapy LLC
ries A financing (1/01)Alta Partners;Califor Discovery Central NeGenentech Inc.;Washington University
Ambergate Trust;ArtaDevelop ene Energy/BioAgricultural Research Service ( 4/06;7/07;8/07;7/07;4/08;11/05
Forest Laboratories A. M. Pappas & AssocDevelop and Anti-infectMeiji Seika Kaisha Ltd. 6/92;9/92;Synthesis-based molecular des
es A financing (10/05) MPM Capital;NomuraAcquire, d Autoimmune Novartis Pharma AG;Undiscose 6-Sep Fermentation and cell cultivatio
Provide in Contract Research Organization;Drug Discovery Cancer therapeutics
Raised $23M (2001);RaiAlta Partners;GIMV;GDiscover, Drug DiscoForest Laboratories Inc.;GlaxoSmithKline plAnti-endocrine therapies targe
Inverness Medical Innovations Inc. Develop, mCardiovascu AmeriSource Health Corp.;Boule1992;1992;1991;1997
Omnicare Inc. Provide th Contract Research Organization 7/09;7/06;10/08;4/04;8/07;1/04;1/07;7/0
Takara Bio Inc. Help accel RNA interfBayer HealthCare;Cellomics Inc. Focus in on inflammation and h
Mission: DeCancer Adamis Pharmaceuticals Corp.
ries A financing (9/05)Astellas Venture;Charter Life Sc Central Nervous System Disorders;Drug Di 4/06;;3/04RAN-loaded dendriotic cell-bas
Support bioBiologicals;Molecular Biology 6/05;9/05;Supplies pathway analysis and
Research, Drug Delivery/Design/Formulation;Wound Healing
Magnetic SSamyang Optics Co. LOffer a widMolecular Bayer;Biocare LLC;Bioer, China; 8-Jan
ivate placement of 27.Adage Capital Manage In-license Cancer BTG;Emory University;LEO Phar 6-Jul RetroMetabolic (ARM) technol
Acorn Campus Venture As an oncoContract RPfizer Inc. 10-Jun The company's technology is lic
ries B financing (5/05)BioVentures Investor Develop noCancer;DruUniversity of Arizona 5-Sep LAL methodology and test instr
Small Business Innovative Research (SBIR) gRevolutioniRNA interfBoston University School of Medicine;Daiichi Pharmaceutical Co. Ltd.;Eli L
Cancer;Instrumentation;Diagnostics
of Series 3 convertible preferred stock (11/ Design, maFertility Tests;Diagnostics 7/09;4/06;microRNA diagnostics and ther
BA Venture Partners;GBuild unprCancer;GenFujirebio Diagnostics;Mayo Cli ;;;;8/95;12Founded in 1987 to commercia
es B financing (4/07) Develop noDiabetes Therapeutics 2/08;2/05 Athenix is a leading biotechnol
 Develop a Anti-infla Peregrine Pharmaceuticals Inc. 1989 Purification of proteins from hu
Exploit th Protein PuMediBIC
Provide pi Combinator Cephalon Inc.;Daylight Chemical Informat Focus is on the development o
Merck KGaA (see separate entry) Tissue Cul Chromagen Inc.;Dendritic Nano 5-Jul Automation and technologies t
Endress+Hauser Group Balance groWaste Treatment;Veterinary Vaccines;Biohe ;;
ries A financing (3/07) DevelopingTherapeutics;Infectous diseases;Diagnostic 6-Jan Gene based therapeutics throu
Focusing efCancer Abbott Laboratories;Actinium Ph9/08;9/08;Discovers and develops novel s
es B financing (11/09) ARCH Venture PartnerDevelop thStem Cell Research;Cancer Develop high throughput patch
s A financing Latterell Venture PartDevelop thAutoimmune Lonza Group Ltd. Biostatistics, data management
Europe Corp.;Tukholma Adage Capital Manage Discovery, Diabetes TAstellas Pharma Inc.;Astellas Pharma Inc.; Life science reagents and fine c
es A financing (5/02); Advanced TechnologyFocus on idDrug DiscoBiosite Inc.;Boehringer Ingelheim GmbH;DSynthetic peptides, reagents, b
harmaceuticals Adams Street PartnerDiscover a TherapeutiEdison Pharmaceuticals Inc. Plant breeding to develop impr
Design, devRNA interference/Gene Silencing;Reagents/Research Materials;Genetic Engineering
Danisco A/S Develop, mFine ChemiAblynx;BioMarin Pharmaceutical3/05;8/06
GenenFUND Roche HoldGenentechTo be the lTherapeutiAbgenix Inc.;AC Immune Ltd.;Alt4/96;7/97;5/92;1989;1995;12/92;3/04;8/
Received aAs a leaderProtein PuDiversa Corp.;DSM;DSM;Kyowa 5 H/05;endedLonger-acting Kogenate produc
Develop, mGenomics;Sofware Programs;Proteomics 6/09;10/08
vate placement (2/04); Atlas Equity;Coqui CaHana BiosciCancer Albert Einstein College of Medicine;CenterCustom plasmid preparation;O
Domain Associates;AdCommercial Pharmacogenomics/Personalized Medicine; 1994 Rapid biosensor to detect and
hemical Diagnostics Ltd., Berkshire, UK Maintain aImmunodiagnostics;Instrumentation;Infect3/06;3/06;Developing product technologi
Stratagene Corp. (see separate entry) Promote grAllergy/AuInternational Reagents Corp. (Kobe, Japan);Vital Scientific NV (Netherland
Develop proTherapeutiMemorial Sloan Kettering Cancer9/03;12/04Solid Phase Reversible Immobi
es A financing Ophthalmic Products ;2/04;7/05In house wet labs supported by
72 rue de Charonne;Pari Banexi Ventures Partners Infectous Cambridge Laboratories Ltd.;Genesis Phar Community acquired pneumon
Combine aDNAs Probes Janssen Pharmaceutical;Seikagaku Corp. BIND Medicinal Nanoengineeri
Develop andProtein PuGenzyme Molecular Oncology Patented technology relates to
Provide th Autoimmune Caribbean Microparticles Corp.
Accel Partners;AffymeMission:;HBioinformaAstellas Pharma Inc.;Asuragen;Avalon Pharm Process blood proteins for use
Autoimmune Disorders;Infectous diseases;Allergy/Auto CEE Cell Enrichment and Extrac
Arrowhead Research Arrowhead Research Design, devAnticancerR&D-Biopharmaceuticals 10/04;8/0 Animal research;Monoclonal a
zanine round of financiAlta Partners;BrentwoDevelop the Anti-infectives;Infectous diseases;Cancer;Antivirals; Core technology centers on the
ncing (1/07) Asset Management Co. Develop anDiabetes TAmgen Inc. 1/07;5/06
Abingworth Management;Biogen Therapeutics;Autoimmune Disorders;Cancer Agricultural products, foliar pla
ries A financing and waAlta Partners;Emergi Develop prCancer;RNA Acuity Pharmaceuticals;DirectG 4-Oct Immunohistochemical product
Deliver su Drug DelivCraic Computing;Keck Graduate 10/02;6/03
I Recombinant human therapeu
Japan Energy Corp. Provide medDiagnostics;Fertility/Hormone Tests;Embry 4-Nov Broad spectrum kits and pheno
office:;501 Smyth Road;Ottawa, Ontario;C Design, cr Cancer Lee's Pharmaceutical Holdings HIV/AIDS;Influenza;Rhinovirus;
d financing (2003, 2004Kleiner, Perkins, Cauf Develop imInfectous Antigen Discovery Inc.;Bayer HealthCare AG Animal tissue culture
es A financing (10/04);Aberdare Ventures;DeLeverage prAnti-infla Altea Therapeutics Corp.;Bristo Jul-98
round financing (6/03)5AM Ventures;Alloy VEstablish aTherapeutiGenome Research Foundation of Novartis;Ludwig Institute for Cancer Res
Cancer;Cardiovascular Agents Hepatocellular carcinoma;Lung
es A financing (4/02);Ra5AM Ventures;Alejand Discovery Sofware PAlcon Inc.;CV Therapeutics Inc. 11/07;1/0 Its technology enables nanosca
);Raised $2M (2003) InvestBio Ventures Central Nervous System Disorders;Therapeutic AntiboDevelop diagnostic assays and
ries A financing (5/07)Mustang Ventures;PaDiscover anCancer;Infectous diseases;Drug Discovery ;;10/04; Mechanism-based drug discove
es C financing (7/09) Altitude Funds;ARCH Venture PaCentral Nervous System Disorders High-speed data acquisition pla
 Provide anaGenomics;P Agilent Technologies Inc.;Cure Autism NowBP-001, a soluble TNF receptor
Domain Associates;AlDevelopment of products for aesthetic medicine to ad1993;1993Bioreactors, fermenters, shaker
Develop anPeptide/Protein Synthesis 1991 Development of new reagents
Alloy Ventures;Frazier HealthcarOphthalmicSanten Pharmaceutical Co. Ltd.
ivate offering of preffeJAFCO Develop noMolecular Logical Therapeutics Inc.;Orient Europharma Co. Ltd.;PUMC Pharmaceutic
ries A round of financiDomain Associates;Lat The company Therapeutics;Allergy Therapeutics;Gastrointestinal TeMicrobiology, chemistry and to
ivate financing (6/97); Alta Partners;Bay Cit Developmen Drug DiscoAstellas Pharma Inc.;Ortho-McNei 6-Feb Fluorophore dye chemistry incl
Focused exc Bone Therapeutics;Dermatologics Molecular biology techniques;H
Hitachi Sofware Engineering Co. Ltd. Utilize the ProteomicsRedasof Corp. 10/03;3/07Dedicated to the discovery and
Specialize Infectous Barbara Ann Karmanos Cancer Institute;CitSample preparation product fo
r Biology Manufacturing;Contract Testing SeContinue wBioremediation;Biodefense;DNA Probes;RNA interferen Biological controls and reagent
Develop inn DNA Probes;Drug Monitoring;Immunodiagnostics;Molec Innovating, developing and pro
on NASDAQ--MGRM Pfizer Inc. Leverage thHIV/AIDS TAstraZeneca plc;Avexa Ltd.;Dana-Farber Can Microbial screening;Strain imp
Engaged inTherapeutiDebiopharm SA;Onyx Pharmaceuti 6-Dec Tribody technology--Allows for
Jurilab Ltd.Birndorf B CompletedMission:;BeDiabetes TBecton Dickinson and Co.;Bode TechnologyELISA G products for infectious di
es C financing (3/05) Alta Partners;Apax PaDevelopingNanobiotecDuPont Electronic Technologies
closing of second rounAlexandria Equities;ARCH VenturNanobioteDuPont Central Research & Development;SDeveloping a natural gluco poly
Developmen Diabetes TAsiaPharm Group Ltd.;Glenmark8/99;8/99
P Long wave-length fluorescent c
Genomics;RNA interference/Gene Silencing6/01;10/01;10/02;6/03;9/02
t round of financing ( HBM BioVentures;Forw Drug discoAnti-inflammatory Therapeutics;Anti-infec 6/04;3/06;Developing antibody-dependen
Use propriBiological Abgenix Inc. Use of the yeast Saccharomyce
Develop safCentral NePfizer Inc.;Eli Lilly and Co. Enhancement of automated DN
s A financing (2000) Digital Gene TechnoloNeurome Inc Sofware PElan Corp. plc;ImClone Systems Feb-95 Animal vaccines and other anim
Create andCardiovascular Agents;Infectous diseases;Drug Deliv Utilizing Site-Specific PEGylat
Discovery, Vaccines;Cancer 8/06;10/06The company's proprietary neu
700K to-date (1/06) Maximize sh Anticancers;Cancer DNA genetic testing, custom as
ds of financing;Raised $Asset ManaAwared a $Dedicated Tt ransplantHinya Yamanaka;Juvenile Diabetes Research Offer a wide range of services t
Novozymes A/S Focus is o Infectous diseases;Agriculture;Molecular Biology;Food Industry;DNA/Genetic Synth
The company Diabetes TPresidio Pharmaceuticals Inc. 6/05;6/09;The company's two-part siRNA
s A financing (7/07);RaGBS Venture Partners of AustralBone TheraKissei Pharmaceutical Co. Ltd. 7-May Specific inhibition of calcium re
Contract Research Organization;Consulting 9-Nov Development of antibody thera
es B financing (11/08) Adams Street PartnerImprove can Cancer;DruFluidigm Corp.;GlaxoSmithKline plc
Karl Storz Imaging ManufacturFine Chemicals;Industrial/Laboratory Enzymes;GenetDevelopment platorm is based
Peptide/Protein Synthesis;Reagents/Resear 1991 Activating T cells;Autoloous vac
Drug produTherapeutic Miyarisan Pharmaceutical Co. Ltd.
st round of financing Abingworth Managemen Develop and Cancer Tests;Genomics;Cancer;Diagnostics2/07;3/06
rolina:;Pearl Therapeut5AM Ventures;Clarus Ventures;NPulmonary/Lung Disease/Asthma Tests;Disease Resis Treatment of cardiovascular dis
vate financing (4/01);RBiofrontier Partners; Perlegen ScDiabetes T454 Life Sciences;AstraZeneca Gr1/05;8/03;Fermentation systems and enzy
Develop anBioinformaFDA Center for Drug Evaluation and ResearCarigent drug delivery platorm
ate placement of SeriesJP Morgan;Delphi Vent Phenomix is Diabetes TChiesi Farmaceutici;Genentech Inc. Novel therapeutic strategies to
rmaceutica SA MK Global Ventures;TPursue aggr AnticancerLaboratorios Silanes SA de CV;NV Organon;Approach focuses on lipid med
Infectous diseases;Cancer 1/08;7/09;Focus is on the development o
ies A financing (5/01); A. M. Pappas & AssocDevelop noDrug DelivF. Hoffmann-La Roche Ltd.;Genentech Inc. The company's technology has
ond round private placAnvers LP;CHL Medical Develop anSeparation Equipment/Technology;Drug Del 8-Apr
3);Raised $46M (10/05);Abingworth Managemen Discover, dCardiovascular Agents;Anti-inflammatory 10-Jun
 Research division;Nuclear Transfer divisio Develop teGene TheraUndisclosed 5-Sep
ies A financing;Raised Apax Partners;CSFB PrDevelop neDiagnosticAstraZeneca plc;Bayer Schering 8-Mar
Supply andFermentatiIBEX Technologies Inc. 2/06;2/06;Addressing the problems of effi
Biologicals
Qiagen NV Be a leaderRNA interfInvitrogen Corp. 9/05;12/0 Improve the accuracy of cance
prises Ltd. ;Weizmann SBI Holdings Group Generate aGene TheraInvitrogen Corp.;Mitsubishi Tok 1987;1987;Cancer, chronic kidney disease
ries D financing (10/05Bear Stearns;Biogen Build valueAntivirals Abbott Laboratories;Bioprocessing TechnolSugar-enhanced drug leads
Alnylam PharmaceuticaDiscover, RNA interfCalifornia Institute of Technology;GlaxoSmTransKingdom RNAi technology
es A financing 5AM Ventures;Amgen;Delphi Ven Cardiovascular Agents;Drug Discovery 3/03;12/0 Focus is on the development o
Roche Holding, Ltd. Integrate dCentral NeAgouron Pharmaceuticals Inc.;Al2/06;10/00Technology platorms:;-Sequen
es A financing (7/01);RMDS Capital;Polaris Discover a NeurobioloUndisclosed
Continue i Agriculture Diagnostics;Food Safety Testi 6-Nov
Santen Pharmaceutical Co. Ltd. (see separate entry) OphthalmicVistakon Pharmaceuticals LLC 2/06; 3/08;10/05
Scantibodies Laboratory Inc. (see separate Specialize
l Therapeutic Antibodies;Diagnostics;Fertilit 9-Jun Nanopharmaceuticals and nan
dies Clinical Laboratory;Scantibodies Laboratory Franc Fertility Tests;Reagents/Research Materia 12/07;8/02Patented capillary electrophore
SciGene proInstrumentation --CG201, anti-hCG vaccine, for
Biotechnology Research AssociatDevelop thCombinator Abbott Laboratories;Biosite Dia 9/03;12/03Multiplex inhibitors targeting k
aboratories Japan, Inc.;5-3-7, Koishikawa, Develop, mVeterinary Diagnostics;Fertility Tests;Consulting Services;Diabetes Tests;Biologic
$23M in equity financin3i Bioscience Invest Develop sitBone TheraBiomet;Dyax Corp. Integrated Discovery outSource
Merck & Co. Inc. GeneChem Management Realize theDermatolog Allergan Inc.;ALZA Corp.;Archemix Corp.;B Antisense DNA-based therapeu
ania office:;40 General Highland Capital;Inv Develop, mBiologicalsDreamPharma Corp. 3/04;8/06 Discovery, development and co
on OTC BB--SPTM ManufactureGenetic Engineering;Drug Delivery/Design/Formulati Genetic transformation of cate
Produce paStem Cell University of Pennsylvania 9/03;4/06 Smallpox program, HIV program
nancing (7/05) Provide higStem Cell Cadila Pharmaceuticals and Apol4/97;11/05;4/97
Agilent Technologies Products inDNA/Geneti Affymetrix Inc.;Jingmei Biotech 4-Dec Ingredients for dairy, food and
es B financing (12/07) Alta Partners;SV Life --Forge str Drug Discovery;Therapeutics;Peptide/Protein SynthesFocus is on designing and mana
H. & Q. Life Science Venture Partners (1989)Develop, mVeterinary Abaxis Inc.;Bio-Trends International Inc.; Developing new applications fo
Draper Fisher Juvets Develop anEnergy/Biomass;DNA/Genetic Synthesis;G 4-Feb Focus is on the creation of adva
Hokkaido Venture CapDevelop the RNA interfOncolys BioPharma Inc.;Oncolys BioPharma Inc.;Pfizer Inc.
Takeda Pharmaceutical Bay City Capital;CME Integrate cAnti-infla Biogen Idec Inc.;PPD Inc.;Roche
es A financing (4/02);RA. M. Pappas & AssociDevelop sma OphthalmicCyDex Inc.;Merck KGaA;Wu Xi PharmaTech Co. Ltd.
es D financing (11/09) Aeris Capital AG;Inte Discover, dAutoimmune Disorders;Diagnostics;Pharm7/06;11/0 Molecular biology- and cell bio
Maintain anPeptide/PrVarious collaborations, includin 10-Feb Developing non-toxic signal tra
Develop, mHIV/AIDS Therapeutics;Blood Proteins;Transplantatio Veterinary biologicals and vacc
Theregen isTherapeutics;Cardiovascular Agents 2/05;8/05;RNAi introduction;Systems biol
es A financing (1/06); BB Biotech Ventures;Forward VeAnti-infla Merck KGaA;Ono Pharmaceutical Co. Ltd. Research and development of s
--Grow theCancer;OphMicromet Inc. Obesity, diabetes and hyperten
s A financing (2/08) San Diego Tech CoastDiscover, RNA interfSanofi-Aventis SA 3/02;4/03;Applying novel genetic technol
Provide th Reagents/Research Materials;DNA/Genetic 9-Jun Use of precision deuterium che
es A financing (2/07);RFinTech Global CapitaDiscover, dInfectous dDefense Department's Defense Threat RedTechnology to combat antibioti
Apopka;4051 Fudge Road;Apopka, FL 32703;Phone: (407) Improved Crops;Forest Biotechnology;Consulting ServDeveloping novel therapeutics
et Products Ltd. Neurobiological Diagnostics;Waste Treatment;Mining Biotechnology;Environmental
erred financing (2002) RAM Capital LLC Mission: B Molecular MedImmune Inc.
Vector U.S.A. Reagents/Research Materials;Molecular Bi2000;5/98Products for human gene thera
es A financing (6/09) Index Ventures Develop thDiabetes Therapeutics ELISA products in autoimmune
ncing ($78M in Series AAthenian Venture ParBuild a porAllergy Th Hollister-Stier Laboratories LLC;Paladin LabCorplex hydrogel technology fo
rolina: Commercial Operations;3700 RegencyDevelop, acDrug Discovery;Therapeutics;Anti-inflamm2/05;1/07;6/06;7/09;5/05;1/07;9/09
es A financing (7/06) Alta Partners;Sutter Virobay's vAutoimmune Disorders;Infectous diseases; 10-Mar Focus is on the discovery and d
apies (Beijing) Co. Ltd.DFJ DragonFund;Delphi VenturesBiologicals;Transplantation;Blood Proteins;TherapeutiCombines Arginetix's arginase
ancing (6/07) Address unOphthalmic Products 1995;1997Molecular miology, pre analytic
ManufactureInstrumentation 4/04;6/04;6/05
);Raised $7.6M (12/00);Bay Area Equity Fund;Improve patAutoimmune University of Minnesota Multispectral and polarization
nancing (1/98);Raised $Healthcare Ventures;Discover a TherapeutiBoehringer Ingelheim GmbH;California Institute of Technology (Caltech);
Drug Discovery;Central Nervous System Di 9-Dec HuPrime and HuMark platorm
 BioSenSys, a portable instrument using AbPrivate
Treatments that modulate the grin Phase II Private
The company has developed a ne in clinicals Private
University of Maryland at Baltimore Private
Development of therapies for p in Phase II Private
Cancer indications, including multiple m Private
Focus is on the identification, in Phase IIIPrivate
in Phase II Private
VCM (Visual Cycle Modulation) co in Phase II Private
Developing small molecule, Advan in Phase IIIPrivate
Initial research focus is on adre NDA filed; Private
Integrated antibody discovery and optimiz Private
maceutical Solutions LLC;Beckman Coulter InPrivate
Create differentiated Adnectin in Phase II Private
Private
Private
Discovery and development of nin Phase I/IPrivate
Co.;EMD Serono;F. Hoffmann-La in Phase II Private
PPAR gamma agonists for neuropa in preclinicPrivate
Focus is on the development of cf ompletedPrivate
Using kinase inhibitors to repair neurons, Private
Plant diagnostics;MAbs, cell culture, hybr Private
Skinfusion technology to begin Pha Private
Screening for microbial natural products agPrivate
HIF prolyl hydroxylase inhibitor in Phase IbPrivate
Therapeutics, diagnostics, drug in Phase II Private
in Phase IIIPrivate
Identification, development andin Phase II Private
Technologies include unique electrode surfa Private
Allergy;Lipoproteins;Endotoxin;ImmunoassPrivate
Developing novel medicines to treat viral Private
RNA interference technologies with Allele Private
Yeast-derived products to maximin developPrivate
preparing Private
Development of vaccines based in onPhase I/IPrivate
9;7/08;1/10;2/06 in Phase I cPrivate
Focused on reducing the time, risk, and ovePrivate
STAR technology platorm: to imp in Phase I/IPrivate
n of Sanochemia Pharmazeutika in Phase II Private
Identifying and developing novein Phase II Private
Development of first-in-class di in developPrivate
Armored RNA: RNA standards for viral diagn Private
Combine the power of our KINOMEs in Phase IIIPrivate
Ambrx ReCODE technology (recon in Phase II Private
Selection and testing of inbred and hybrid Private
 Blood assessments for identifying oxidativ Private
Cardiovascular diseases;Cancer prognosticPrivate
Radiolabeled drugs Private
in Phase II Private
Disease targets include pancreain Phase II Private
Development of immune-basedin biopreclini Private
Small molecules to improve the efficacy ofPrivate
Creating No Compromise fuels--renewablePrivate fu
Usage of boron chemistry to devin Phase II Private
Biosensors, novel diagnostic techniques Private
Atrimers are a new class of protein therap Private
Use of somatic hypermutation (SMH) for anPrivate
Fermentation/Microorganism Development;Ge Private
Focusing on protein research in the laboratPrivate
in preclinicPrivate
Diagnostic devices for male fertility--humaPrivate
in Phase I/Private
Small-molecule drugs that disrup in Phase II Private
Monoclonal antibodies, immunoassays, quPrivate
Immunological modulators derived from para Private
ONCase (methioninase) cancer th in late pre Private
Validation of a cell surface tar to begin clPrivate
in preclinicPrivate
optimized Private
7;8/07;7/07;4/08;11/05 in Phase II Private
Synthesis-based molecular design technol Private
Fermentation and cell cultivation Private
Cancer therapeutics completedPrivate
P
Anti-endocrine therapies target in Phase II Private
2;1991;1997 Private
6;10/08;4/04;8/07;1/04;1/07;7/0in Phase II Private
Focus in on inflammation and h in Phase II Private
Private
RAN-loaded dendriotic cell-basein Phase I/IPrivate
Supplies pathway analysis and automated sc Private
in Phase I cPrivate
in Phase II Private
RetroMetabolic (ARM) technology in Phase II Private
The company's technology is licein Phase II Private
LAL methodology and test instrumentationPrivate
ichi Pharmaceutical Co. Ltd.;Eli Lilly and C Private
in preclini Private
microRNA diagnostics and therapeutics forPrivate
Founded in 1987 to commercialize tests anPrivate
Athenix is a leading biotechnoloin greenhou Private
 Purification of proteins from human sera;DiPrivate
Private
Focus is on the development of idn Phase I cPrivate
Automation and technologies that simplifyPrivatet
completedPrivate
Ph
Gene based therapeutics through in Phase II Private
Discovers and develops novel smin Phase II Private
Develop high throughput patch clamp techn Private
Biostatistics, data management, data mon Private
Life science reagents and fine chemical ra Private
Synthetic peptides, reagents, bulk pharmacPrivate
Plant breeding to develop improved hybrids Private
h Materials;Genetic Engineering/Analysis Private
Private
7;5/92;1989;1995;12/92;3/04;8/97;1997;7/ Private
Longer-acting Kogenate product;Gene thera Private
in Phase II Private
Custom plasmid preparation;OligonucleotiPrivate
Rapid biosensor to detect and i conductingPrivate
Developing product technologies for monitPrivate
n);Vital Scientific NV (Netherlands) Private
Solid Phase Reversible Immobilization (SPRPrivate
In house wet labs supported by a cutng ed Private
Community acquired pneumonia;Acute otiti Private
BIND Medicinal Nanoengineering platormPrivate all
Patented technology relates to a blend of pPrivate
Private
Process blood proteins for use in research Private
CEE Cell Enrichment and Extraction technolPrivate
Animal research;Monoclonal antibody devePrivate
Core technology centers on the pentose carPrivate
Private
Agricultural products, foliar plant nutrient Private
Immunohistochemical products for identifiPrivate
Recombinant human therapeuticin Phase II Private
Broad spectrum kits and phenotype MicroArr Private
HIV/AIDS;Influenza;Rhinovirus;Haemophilus Private
Animal tissue culture Private
in field triaPrivate
s;Ludwig Institute for Cancer Research;SanofiPrivate
Hepatocellular carcinoma;Lung, breast andPrivate
Its technology enables nanoscale identific Private
Develop diagnostic assays and kits to detecPrivate
Mechanism-based drug discovery in Phase IIIPrivate
High-speed data acquisition platorm (MP1Private
 BP-001, a soluble TNF receptor that has twPrivate
Bioreactors, fermenters, shakers Private
Development of new reagents used for canPrivate
Private
ma Co. Ltd.;PUMC Pharmaceutical Co. Private
Microbiology, chemistry and toxicology te Private
Fluorophore dye chemistry including synthe Private
Molecular biology techniques;High throughp Private
Dedicated to the discovery and developmen Private
Sample preparation product for proteomicsPrivate
Biological controls and reagents for flow Private
Innovating, developing and produceing prec Private
Microbial screening;Strain improvement, cPrivate
Tribody technology--Allows for tin Phase II Private
ELISA products for infectious disease;Hor Private
Private
Developing a natural gluco polysin Phase II Private
Long wave-length fluorescent cain field triaPrivate
01;10/02;6/03;9/02 in Phase IIIPrivate
Developing antibody-dependentinc Phase I Private
Use of the yeast Saccharomyces cerevisiaePrivate
Enhancement of automated DNA synthesisPrivate
Animal vaccines and other animin field tes Private
Utilizing Site-Specific PEGylat in developPrivate
The company's proprietary neuro in Phase II Private
DNA genetic testing, custom assay developm Private
Offer a wide range of services to clients, Private
od Industry;DNA/Genetic Synth in preclini Private
The company's two-part siRNA del IND approve Private
Specific inhibition of calcium release-act Private
Development of antibody therape in preclin Private
Private
Development platorm is based on three fun Private
Activating T cells;Autoloous vaccines Private
Private
in Phase II Private
Treatment of cardiovascular dis in Phase I cPrivate
Fermentation systems and enzyme applicatPrivate
Carigent drug delivery platorm allows for Private
Novel therapeutic strategies to IND candidPrivate
Approach focuses on lipid mediain preclini Private
Focus is on the development of in preclinicPrivate
The company's technology has de in preclinicPrivate
Private
in Phase II Private
 in Phase I cPrivate
Private
Addressing the problems of efficacy and toPrivate
in preclinicPrivate
Improve the accuracy of cancer detection ba Private
Cancer, chronic kidney disease and immunPrivate
Sugar-enhanced drug leads in lead optPrivate
TransKingdom RNAi technology IND us accepte Private
Focus is on the development of in Phase II Private
Technology platorms:;-Sequencing and cDNA Private
Private
in Phase II Private
in Phase II/Private
Nanopharmaceuticals and nanobiology; dev Private
Patented capillary electrophoresin preclinicPrivate
--CG201, anti-hCG vaccine, for in clinicals Private
Multiplex inhibitors targeting key angiog Private
vices;Diabetes Tests;Biologic in preclinicPrivate
Integrated Discovery outSource platorm; Private
Antisense DNA-based therapeutics for AIDPrivate
Discovery, development and comm completedPrivate
Ph
Genetic transformation of caterpillars to Private
Smallpox program, HIV program,in Phase I cPrivate
Private
Ingredients for dairy, food and beverage, Private
Focus is on designing and managing clinicalPrivate
Developing new applications for drug deli Private
Focus is on the creation of advanced algor Private
ma Inc.;Pfizer Inc. in Phase II Private
Private
Private
Molecular biology- and cell biology-based pPrivate
Developing non-toxic signal tra to begin cliPrivate
Veterinary biologicals and vaccines;AnimalPrivate
RNAi introduction;Systems biolovarious staPrivate
Research and development of sma in Phase II Private
Obesity, diabetes and hypertension Private
Applying novel genetic technology that mak Private
Use of precision deuterium chem in Phase I cPrivate
Technology to combat antibiotic-in preclinicPrivate
Developing novel therapeutics in the emergi Private
g Biotechnology;Environmental Analysis;<I Private
Private
Products for human gene therapy completedPrivate
P
ELISA products in autoimmune and vasculaPrivate
 Corplex hydrogel technology forin Phase I cPrivate
7;6/06;7/09;5/05;1/07;9/09 Private
Focus is on the discovery and d in Phase I/IPrivate
Combines Arginetix's arginase i in preclinicPrivate
Molecular miology, pre analytic systems, Private
in Phase IIIPrivate
Multispectral and polarization i in developPrivate
stitute of Technology (Caltech); in Phase II Private
HuPrime and HuMark platorms Private